Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-11-16
Original SEC Filing: Click here

---

Webplus: SVA/20121116/6-K/2_EX-99.1/000.htm SEC Original: v328746_ex99-1.htm
Sinovac Reports Unaudited Third Quarter 2012 Financial Results – Conference call scheduled for Thursday, November 15, 2012 at 8:00 AM EST– Beijing – November 15, 2012 – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of vaccines in China, announced today its unaudited financial results for the third quarter ended September 30, 2012. Third Quarter 2012 Financial Highlights (year-over-year comparisons

---

---

Webplus: SVA/20121116/6-K/1/000.htm SEC Original: v328746_6k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F X ___ Form 40-F _________ SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer 6-K 1 v328746_6k.htm FORM 6-K

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2012-11-16CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085